At a glance
ClinicalIndex Comparison RecordN/ACompleted· 165 enrolled
Drug / intervention
Etoricoxib +1 moredrug
Likely dose
Etoricoxib 120 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Is There Any Analgesic Benefit From Preoperative vs. Postoperative Etoricoxib Administration in Total Knee Arthroplasty?
In Brief
A clinical study evaluating Etoricoxib and Placebo for Postoperative Pain. Completed, enrolled 165 participants across 1 site.
Detailed Summary
Evaluation of the efficacy of preemptive versus postoperative administration of etoricoxib in total knee arthroplasty (TKA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesRomania
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
Primary CompletionAug 2014
Study CompletionSep 2014
First PostedAug 2015
TodayJul 2026
First PostedAug 27, 2015
Enrollment StartJan 1, 2014
Primary CompletionAug 1, 2014
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.8 years ago
Interventions
Etoricoxibdrug
120 mg etoricoxib PO administered 1 h preoperative for group A; group B received 120 mg etoricoxib PO at the end of the surgery.
Placebodrug
Group A received 1 sham pill PO at the end of the surgery; group B received 1 sham pill PO 1 h preoperative and group C received sham pill PO 1 h preoperative and 1 sham pill PO at the end of the surgery.